Quality of randomized controlled trials reporting in the primary treatment of brain tumors

Journal of Clinical Oncology

Volumn 24, Issue 7, 2006, Pages 1136-1144

  Lai, Rose ^a   Chu, Rong ^a   Fraumeni, Michael ^a   Thabane, Lehana ^a  

^a CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; EMBASE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGY; HEALTH CARE QUALITY; MEDICAL RECORD; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; STANDARD;

BRAIN NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; JOURNALISM, MEDICAL; MEDICAL RECORDS; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 33644983832     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.1179     Document Type: Article

References (25)

1. Deangelis LM: Brain tumors. N Engl J Med 344:114-123, 2001
2. Stupp R, Mason WP, Van Den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
3. Moher D, Pham B, Jones A, et al: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613, 1998
4. Chang SM, Parney IF, Huang W, et al: Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564, 2005
5. Wieand HS: Randomized phase II trials: What does randomization gain? J Clin Oncol 23:1794-1795, 2005
6. Moher D, Schulz KF, Altman DG: The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194, 2001
7. Huwiler-Muntener K, Juni P, Junker C, et al: Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 287:2801-2804, 2002
8. Balk EM, Bonis PA, Moskowitz H, et al: Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 287:2973-2982, 2002
9. Schulz KF, Chalmers I, Hayes RJ, et al: Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412, 1995
10. Schulz KF, Altman DG, Moher D: Allocation concealment in clinical trials. JAMA 288:2406-2407, 2002
11. Alderson P, Green S, Higgins JPT: Assessment of study quality, in Higgins JPT, Green S (ed): Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. Chichester, UK, John Wiley & Sons Ltd, 2005, pp 87-95
12. Hollis S, Campbell F: What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319:670-674, 1999
13. Devereaux PJ, Manns BJ, Ghali WA, et al: The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 23:380-388, 2002
14. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33:159-174, 1977
15. Zeger SL, Liang KY, Albert PS: Models for longitudinal data: A generalized estimating equation approach. Biometrics 44:1049-1060, 1988
16. Zheng B: Summarizing the goodness of fit of generalized linear models for longitudinal data. Stat Med 19:1265-1275, 2000
17. Junker CA: Adherence to published standards of reporting: A comparison of placebo-controlled trials published in English or German. JAMA 280:247-249, 1998
18. Bhandari M, Richards RR, Sprague S, et al: The quality of reporting of randomized trials in the Journal of Bone and Joint Surgery from 1988 through 2000. J Bone Joint Surg Am 84:388-396, 2002
19. Liberati A, Himel HN, Chalmers TC: A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 4:942-951, 1986
20. Djulbegovic B, Lacevic M, Cantor A, et al: The uncertainty principle and industry-sponsored research. Lancet 356:635-638, 2000
21. Soares HP, Daniels S, Kumar A, et al: Bad reporting does not mean bad methods for randomised trials: Observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 328:22-24, 2004
22. Devereaux PJ, Choi PT, El-Dika S, et al: An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 57:1232-1236, 2004
23. Pildal J, Chan AW, Hrobjartsson A, et al: Comparison of descriptions of allocation concealment in trial protocols and the published reports: Cohort study. BMJ 330:1049, 2005
24. De Angelis CD, Drazen JM, Frizelle FA, et al: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 352:2436-2438, 2005
25. Krzyzanowska MK, Pintilie M, Brezden-Masley C, et al: Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: Guidelines for improved reporting. J Clin Oncol 22:1993-1999, 2004